Detailed price information for Apellis Pharmaceuticals Inc (APLS-Q) from The Globe and Mail including charting and trades.
Apellis APLS stock uptick in the last six months can be significantly attributed to the FDA’s approval of Syfovre (pegcetacoplan injection) to treat geographic atrophy (GA) secondary to age-related ...
Investors in Apellis Pharmaceuticals Inc (Symbol: APLS) saw new options become available today, for the September 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...
Detailed price information for Apellis Pharmaceuticals Inc (APLS-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results